Trial Outcomes & Findings for Peri-Implant Healing Around Two Different Machined-Collar Designs After 25 Years of Function (NCT NCT03862482)

NCT ID: NCT03862482

Last Updated: 2021-06-14

Results Overview

Distance between first bone-to-implant contact point (fBIC) and microgap (MG) at the crest was measured (mm) at mesial and distal sides of each implant/abutment complex on conventional peri-apical radiographs using a standardized equipment and measurement protocol (Camarda, et al., 2018) after 25 years of function. Values fBIC-MG (Mean ± SE) ("-" for bone loss) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Results posted on

2021-06-14

Participant Flow

Recruitment date: May 1st - May 30th, 2019. Recruitment location: Faculty of Dental Medicine

Unit of analysis: Implants

Participant milestones

Participant milestones
Measure
Active Comparator: Brånemark® (B) 2, Swede-Vent® (SW) 2, Screw-Vent® (SC) 1 (Configuration 1)
Device: Brånemark® implant placed at sites 2 (left medial) and 5 (right distal), Swede-Vent® implant placed at sites 1 (left distal) and 4 (right medial), Screw-Vent® implant placed at site 3 (para symphysis) between mandibular foramen
Experimental: Brånemark® (B) 1, Swede-Vent® (SW) 2, Screw-Vent® (SC) 2 (Configuration 2)
Device: Brånemark® implant placed at site 3 (para symphysis), Swede-Vent® implant placed at sites 2 (left medial) and 5 (right distal), Screw-Vent® implant placed at sites 1 (left distal) and 4 (right medial) between mandibular foramen
Experimental: Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)
Device: Brånemark® implant placed at sites 1 (left distal) and 4 (right medial), Swede-Vent® implant placed at site 3 (para symphysis), Screw-Vent® implant placed at sites 2 (left medial) and 5 (right distal) between mandibular foramen
Overall Study
STARTED
8 40
8 40
6 30
Overall Study
COMPLETED
8 39
8 38
6 30
Overall Study
NOT COMPLETED
0 1
0 2
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Peri-Implant Healing Around Two Different Machined-Collar Designs After 25 Years of Function

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1)
n=40 Implants
Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SW (Swede-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SC (Screw-Vent® dental implant unit) placed at site 3 (para symphysis) for a total of 40 dental implant units (16 B, 16 SW, 8 SC), all between mandibular foramen
Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2)
n=40 Implants
Device placement: B (Brånemark® dental implant unit) placed at site 3 (para symphysis), SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal), SC (Screw-Vent® dental implant unit) placed at sites 1 (left distal) and 4 (right medial) for a total of 40 dental implant units (eight B, 16 SW, 16 SC), all between mandibular foramen
Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3)
n=30 Implants
Device placement: B (Brånemark® dental implant unit) placed at sites 1 (left distal) and 4 (right medial), SW (Swede-Vent® dental implant unit) placed at site 3 (para symphysis), SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) for a total of 30 dental implant units (12 B, six SW, 12 SC), all between mandibular foramen
Total
n=110 Implants
Total of all reporting groups
Age, Customized
Age (Years): Mean ± Standard Deviation
69.4 years
STANDARD_DEVIATION 6.12 • n=5 Participants
71.5 years
STANDARD_DEVIATION 5.09 • n=7 Participants
70.5 years
STANDARD_DEVIATION 4.11 • n=5 Participants
70.45 years
STANDARD_DEVIATION 5.34 • n=4 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
5 Participants
n=7 Participants
2 Participants
n=5 Participants
11 Participants
n=4 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
11 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
White
8 Participants
n=5 Participants
8 Participants
n=7 Participants
6 Participants
n=5 Participants
22 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Total number of implant units per study arm
40 Number count
n=63 Implants
40 Number count
n=85 Implants
30 Number count
n=148 Implants
110 Number count
n=110 Implants

PRIMARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implant units (40 Configuration 1, 40 Configuration 2, and 30 Configuration 3). One implant unit (SW, Configuration 1) had fractured, and two implant units (B and SW, Configuration 2) were excluded due to technical difficulties with radiographic technique. Consequently, 107 implant units were were analyzed.

Distance between first bone-to-implant contact point (fBIC) and microgap (MG) at the crest was measured (mm) at mesial and distal sides of each implant/abutment complex on conventional peri-apical radiographs using a standardized equipment and measurement protocol (Camarda, et al., 2018) after 25 years of function. Values fBIC-MG (Mean ± SE) ("-" for bone loss) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three Configurations
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations
-1.77 mm
Standard Error 0.18
Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three Configurations
Total 35 Brånemark® dental implant units analyzed for all three Configurations
-0.85 mm
Standard Error 0.18
Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant Units in All Three Configurations
Total 36 Swede-Vent® dental implant units analyzed for all three Configurations
-1.00 mm
Standard Error 0.18

SECONDARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implants (B=36, SW=38, SC=36). One implant (B Configuration 1) had fractured; two (B and SW Configuration 2) had technical issues. 107 implants were analysed after 25 years of function. Values (Mean ± SE) were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC implant units in all three Configurations

Mobility was measured by applying manual pressure on the handles of two instruments, each placed on opposite sides of the prostheses and abutments, and was recorded as 0 (no mobility or looseness) or 1 (mobility or looseness). Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of Function
Total 35 Brånemark® implants analyzed for all 3 Configurations
0 Implants
Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of Function
Total 36 Swede-Vent® implants analyzed for all 3 Configurations
0 Implants
Comparison of Prosthesis, Abutment, and Implant Mobility or Looseness: Absence (0) or Presence (1) of Mobility or Looseness After 25 Years of Function
Total 36 Screw-Vent® implants analyzed for all 3 Configurations.
0 Implants

SECONDARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 implants (B=36, SW=38, SC=36). One implant (B Configuration 1) had fractured; two (B and SW Configuration 2) had technical issues. 107 implants were analysed after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC implant units in all three Configurations

Height of the keratinized tissue was measured (mm) using a ColorVue UNC12 Hu-Friedy probe on the buccal and lingual implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of Function
Total 35 Brånemark® dental implant units analyzed for all three Configurations
0.67 mm.
Standard Error 0.08
Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of Function
Total 36 Swede-Vent® dental implant units analyzed for all three Configurations
0.51 mm.
Standard Error 0.08
Comparison of Soft Tissue Healing: Height (mm) of Keratinized Tissue After 25 Years of Function
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations
0.74 mm.
Standard Error 0.10

SECONDARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Using a ColorVue UNC12 Hu-Friedy probe, probing depth was measured (mm) on the buccal, lingual, mesial and distal implant/abutment surfaces. Values (Mean ± SE) were calculated, recorded and compared between B and SW, between B and SC and between SW and SC for Configuration 1(Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent ®1, Screw-Vent® 2)

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of Function
Total 36 Swede-Vent® dental implant units analyzed for all three Configurations
2.34 mm
Standard Error 0.18
Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of Function
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations
2.29 mm
Standard Error 0.18
Comparison of Soft Tissue Healing: Probing Depth (mm) After 25 Years of Function
Total 35 Brånemark® dental implant units analyzed for all three Configurations
2.09 mm
Standard Error 0.14

SECONDARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Absence (0) or presence (1) of plaque and/or gingival bleeding on probing was evaluated using the dichotomous/binary plaque index (dPI) (Galgut, P. A., 1999) and bleeding index (dBI), respectively (Galgut, P.A., 1999). Values (Mean ± SE) were compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent ®1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 35 Brånemark® dental implant units analyzed for all three Configurations. Plaque Mean dPI
0.40 score on a scale
Standard Error 0.06
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 36 Swede-Vent® dental implant units analyzed for all three Configurations. Plaque Mean dPI
0.42 score on a scale
Standard Error 0.06
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations. Plaque Mean dPI
0.43 score on a scale
Standard Error 0.06
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 35 Brånemark® dental implant units analyzed for all three Configurations. Bleeding Mean dBI
0.48 score on a scale
Standard Error 0.06
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations. Bleeding Mean dBI
0.44 score on a scale
Standard Error 0.06
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Plaque and/or Gingival Bleeding After 25 Years of Function
Total 36 Swede-Vent dental implant units analyzed for all three Configurations. Bleeding Mean dBI
0.47 score on a scale
Standard Error 0.05

SECONDARY outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: 22 participants in all Configurations contributed 110 units (B=36, SW=38, SC=36). 107 were analyzed (B=35. SW=36, SC=36). fBIC-MG was measured at mesial and distal sides of each unit after 25 years of function. Mean (Mean ± SE) values were calculated, recorded and compared between all B and all SW, between all B and all SC and between all SW and all SC dental implant units in all three Configurations

Absence (0) or presence (1) of purulent exudate on probing was evaluated. Values (Mean ± SE) were recorded, and compared between B and SW, between B and SC and between SW and SC for Configuration 1 (Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1), Configuration 2 (Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2), and Configuration 3 (Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2)

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=107 Implants.
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of Function
Total 35 Brånemark® dental implant units analyzed for all three Configurations. Purulent exudate
0 Implants.
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of Function
Total 36 Swede-Vent dental implant units analyzed for all three Configurations. Purulent exudate
1 Implants.
Comparison of Soft Tissue Healing: Absence (0) or Presence (1) of Purulent Exudate After 25 Years of Function
Total 36 Screw-Vent® dental implant units analyzed for all three Configurations. Purulent exudate
0 Implants.

OTHER_PRE_SPECIFIED outcome

Timeframe: After 25 years (24.6 ± 0.19 years, mean ± SE) of function

Population: Each of the 22 participants contributed five implants for a total of 110 B=36, SW=38, SC=36) for all three configurations. However, only 95 implants (19 participants) were analyzed (B=32, SW=32, SC=31) for all three configurations in order to compare the two measurement systems. One implant (SW, Configuration 1) was fractured. Two implants (one B and one SW, both Configuration 2) had technical issues with radiographs. Twelve implants could not be measured due to participant refusal

Conventional peri-apical radiology and phosphor-plate digital technology (Digora System™, Digora OptimeTM, Sporedex Dental Co., Tuusula, Finland) were used with the standardized equipment to take peri-apical radiographs on 95 implant/abutment units (Camarda, et al., 2018; Bhaskaran, et al., 2005). Following calibration, the distance between the first-bone-to-implant-contact-point and the crestal-microgap (fBIC-MG) was measured (mm) at the mesial and distal aspects of each implant/abutment unit after 25 years of function. Values (Mean ± SE) fBIC-MG were recorded for each of the two measurement systems. ICC (Intraclass Correlation Coefficient, two-way, mixed effect model) and Bland-Altman Limits of agreement (Bland \& Altman, 1986) were used to evaluate the level of agreement between the two systems

Outcome measures

Outcome measures
Measure
All Participants (Configurations 1, 2, and 3)
n=95 Implants
Configuration 1: Device placement: B (Brånemark® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 2: Device placement SW (Swede-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal) Configuration 3: Device placement SC (Screw-Vent® dental implant unit) placed at sites 2 (left medial) and 5 (right distal)
Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of Function
Bland-Altman Limits of agreement (Bland & Altman,1986)
0.15 Implants
Interval -1.21 to 1.51
Comparison of Two Measurement Systems Used to Evaluate Peri-implant Bone Healing After 25 Years of Function
ICC (Intraclass Correlation Coefficient two-way, mixed effect model)
0.93 Implants
Interval 0.89 to 0.95

Adverse Events

Active Comparator: Brånemark® 2, Swede-Vent® 2, Screw-Vent® 1 (Configuration 1).

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental: Brånemark® 1, Swede-Vent® 2, Screw-Vent® 2 (Configuration 2).

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Experimental: Brånemark® 2, Swede-Vent® 1, Screw-Vent® 2 (Configuration 3).

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Aldo Joseph Camarda

Université de Montréal

Phone: 514-343-7124

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place